- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07310329
High-Dose Vitamin D Supplementation and Exercise Effects on Vitamin D Metabolites in Professional Football Players (VitD-Football)
Effects of High-Dose Vitamin D Supplementation and Physical Exercise on Vitamin D Metabolites in Professional Football Players: A Pilot Study
This randomized, single-blind, placebo-controlled pilot study investigated the effects of high-dose vitamin D₃ supplementation and football-specific physical exercise on vitamin D metabolite concentrations in professional male football players. The study aimed to evaluate the acute response of circulating vitamin D metabolites, including 25-(OH)D₃, 24,25-(OH)₂D₃, and 3-epi-25-(OH)D₃, following a single oral dose of 500,000 IU cholecalciferol combined with high-intensity intermittent exercise typical of competitive football.
Twenty professional football players from a Polish top-division club participated in the study. Participants were randomly assigned to either the supplementation group (SGP) receiving 500,000 IU of vitamin D₃ or the placebo group (PGP) receiving an identical volume of placebo oil. The intervention was administered 48 hours prior to an intra-squad game. Blood samples were collected at three time points: baseline (T3), pre-match (T4), and post-match (T5). The primary outcome was the change in serum 25-(OH)D₃ concentration. Secondary outcomes included changes in 24,25-(OH)₂D₃ and 3-epi-25-(OH)D₃ levels, as well as their ratios. The study also assessed whether physical exercise modulates vitamin D metabolism.
The findings demonstrated that high-dose vitamin D₃ supplementation significantly increased serum 25-(OH)D₃ (↑198%) and 3-epi-25-(OH)D₃ (↑444%) levels, while football-specific exercise itself induced moderate increases in vitamin D metabolites. The results suggest that skeletal muscle may play a key role in vitamin D storage and release in response to exercise. The supplementation was well tolerated, with no adverse events observed.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This pilot study was designed to explore the combined effects of high-dose vitamin D₃ supplementation and acute physical exercise on vitamin D metabolism in professional football players. The study responds to growing scientific interest in understanding how vitamin D status influences performance, recovery, and muscle function in athletes. While most previous studies have focused on chronic, low-to-moderate supplementation, this trial examined the response to a single, pharmacological dose of cholecalciferol in a controlled experimental setting.
Study Design
The study employed a randomized, single-blind, placebo-controlled, parallel-group design. Participants were randomly assigned to one of two groups:
Supplementation Group (SGP) - received a single oral dose of 500,000 IU vitamin D₃ (Vigantol Oil, P&G Health, Germany);
Placebo Group (PGP) - received an identical amount of placebo (vegetable oil).
The supplementation was administered 48 hours before a standardized intra-squad football match (ISG), conducted under conditions simulating a competitive game. All players followed the same training schedule and diet during the study.
Participants
A total of 20 professional male football players (aged 18-35) from a Polish top-league club volunteered to participate. Inclusion criteria included active professional status, regular training participation, and no use of vitamin D or calcium supplements in the previous 3 months. Exclusion criteria included musculoskeletal injuries, metabolic disorders, or refusal to sign informed consent.
Measurements
Blood samples were collected at three time points:
T3: baseline (before supplementation),
T4: 48 hours post-supplementation (pre-match),
T5: immediately after the intra-squad game.
Serum concentrations of 25-(OH)D₃, 24,25-(OH)₂D₃, and 3-epi-25-(OH)D₃ were determined using LC-MS/MS. Additional biochemical variables (hemoglobin, glucose, testosterone, cortisol, ferritin, calcium, CK) were analyzed to monitor physiological status.
Outcomes
Primary Outcome: Changes in serum 25-(OH)D₃ concentrations after supplementation and exercise.
Secondary Outcomes: Changes in 24,25-(OH)₂D₃ and 3-epi-25-(OH)D₃ levels, metabolite ratios.
Ethics
The study was approved by the Ethics Committee of the Wroclaw University of Health and Sport Sciences (Resolution No. 1/2024, March 1, 2024). All participants signed written informed consent.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Dolnyśląsk
-
Wroclaw, Dolnyśląsk, Poland, 51-612
- Wroclaw University of Health and Sport Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male professional football players aged 18-35 years
- Actively training and competing in the Polish first football league
- No vitamin D or calcium supplementation during the previous 3 months
- No injuries or illnesses affecting participation
Exclusion Criteria:
- Current musculoskeletal injury or illness
- Chronic metabolic, endocrine, or renal disorders
- Use of vitamin D or calcium supplements
- Refusal or inability to sign informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Supplementation Group (SGP)
Participants in this group received a single oral dose of 500,000 IU of vitamin D₃ (Vigantol Oil, P&G Health, Germany) 48 hours before the intra-squad football match (ISG).
Blood samples were collected before supplementation and both before and after the ISG to evaluate changes in vitamin D metabolites.
|
A single oral dose of 500,000 IU vitamin D₃ (Vigantol Oil, P&G Health, Germany) was administered 48 hours before the intra-squad football match to assess its acute effects on vitamin D metabolite concentrations.
|
|
Placebo Comparator: Placebo Group (PGP)
Participants in this group received a single oral dose of placebo oil identical in color and consistency to the vitamin D₃ solution.
Blood samples were collected at the same time points as in the supplementation group to assess vitamin D metabolite changes.
|
A single oral dose of vegetable oil matching the vitamin D₃ solution in color and consistency was administered 48 hours before the intra-squad football match.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in serum 25(OH)D₃ concentration
Time Frame: Baseline (before supplementation), 48 hours after supplementation, and immediately after the football match (2 days after supplementation).
|
Serum concentrations of 25(OH)D₃ will be measured using isotope-dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS).
The primary outcome assesses the effect of a single high-dose vitamin D₃ supplementation combined with physical exercise on 25(OH)D₃ concentration in professional football players.
|
Baseline (before supplementation), 48 hours after supplementation, and immediately after the football match (2 days after supplementation).
|
|
Changes in serum 24,25-dihydroxyvitamin D₃ [24,25(OH)₂D₃] concentration
Time Frame: Baseline (T3), 48 hours post-supplementation (T4), and post-exercise (T5)
|
To evaluate the effect of vitamin D₃ supplementation and physical exercise on 24,25(OH)₂D₃ levels using ID-LC-MS/MS.
|
Baseline (T3), 48 hours post-supplementation (T4), and post-exercise (T5)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in metabolite ratios (25(OH)D₃:24,25(OH)₂D₃ and 25(OH)D₃:3-epi-25(OH)D₃)
Time Frame: Baseline (before supplementation), 48 hours after supplementation, and immediately after the football match (2 days after supplementation).
|
To assess changes in the ratios between major vitamin D metabolites as indicators of metabolic transformation rate and vitamin D turnover in response to supplementation and physical activity.
|
Baseline (before supplementation), 48 hours after supplementation, and immediately after the football match (2 days after supplementation).
|
Collaborators and Investigators
Investigators
- Principal Investigator: Anna Książek, PhD Eng.; Associate Professor, Department of Biological Principles of Physical Activity ; Wroclaw University of Health and Sport Sciences
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AWF-VitD-Football-2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Athletes
-
PepsiCo Global R&DCompletedFluid Intake in Athletes | Sweating Rate in Athletes | Sweat Chloride Concentration in AthletesUnited States
-
Food and Nutrition Research Institute, PhilippinesPhilippine Council for Health Research & DevelopmentNot yet recruitingAthletes | Nutrition Physiology | The Focus of This Study is to Describe the Body Composition and Metabolism of Athletes and Non-athletes
-
Bozok UniversityThe Scientific Research Project Fund of Yozgat Bozok UniversityCompletedAthletes | Sports Performance | Visual-Motor Processing | Neuro-Psychophysiological Responses in AthletesTurkey (Türkiye)
-
University of BrasiliaNot yet recruiting
-
Universiti Putra MalaysiaNot yet recruiting
-
Hong Kong Metropolitan UniversityCompleted
-
São Paulo State UniversityCompleted
-
Dokuz Eylul UniversityRecruitingAthletes | VolleyballTurkey
-
University of PalermoUniversity of Urbino "Carlo Bo"CompletedAthletes | CyclistsItaly
Clinical Trials on Vitamin D₃
-
University of Ilorin Teaching HospitalMayo ClinicNot yet recruitingProstate Cancer (Adenocarcinoma) | Vitamin D on Tumor Response and Inflammatory MarkersNigeria
-
PfizerTerminated
-
Universidad Autónoma Benito Juárez de OaxacaNational Council of Science and Technology, MexicoCompletedObesity | Muscle Weakness | Vitamin D Deficiency | Sarcopenia | Aging | Sarcopenic Obesity | Obesity (Disorder) | Sarcopenia in Elderly | Muscle Mass | Functional Decline | Age-Related Loss of Skeletal Muscle Mass | Older Adults (65 Years and Older) | Muscle Strengh | Vitamin D 25-Hydroxylase DeficiencyMexico
-
Umeå UniversityRegion SkaneCompleted
-
Bangladesh Medical UniversityEnrolling by invitationHypovitaminosis D | Major Depressive Disorder (MDD)Bangladesh
-
Karadeniz Technical UniversityActive, not recruitingThose Who Provided Written Informed Consent | Female Gender | Aged 18 Years and Older | Hypothyroidism Disease | Serum Vitamin d < 30 ng/dlTurkey (Türkiye)
-
Fundación Cardiovascular de ColombiaUniversidad Industrial de Santander; Farma de Colombia SACompletedVitamin D Deficiency | Overweight and Obesity | Overweight AdolescentsColombia
-
Khon Kaen UniversityCompletedEndometriosis | Vitamin D Status | Vitamin D Deficiency/InsufficiencyThailand
-
Bursa City HospitalCompletedVitamin D Deficiency | COVIDTurkey (Türkiye)
-
Nutrition Institute, SloveniaSlovenian Research Agency; Higher School of Applied Sciences (VIST); Valens Int...CompletedVitamin D DeficiencySlovenia